Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases

This study examined the risk factors and outcomes of autoimmune alopecia areata (AA) in patients with inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, using a retrospective case-control design with 58 cases and 90 controls. It found that IBD patients who developed AA were more likely to have been treated with tumor necrosis factor (TNF) antagonists at the time of AA onset. The severity of AA was a significant predictor of its resolution, with severe cases less likely to improve. Despite ongoing IBD therapy, many patients showed improvement in AA, suggesting a potential link between IBD treatments, particularly anti-TNF therapy, and the development of AA. The study indicates a possible genetic predisposition to immune-mediated dysregulations but is limited by its moderate sample size and retrospective nature, necessitating further research with larger cohorts.